Catalyst Wire Dossier Catalyst Wire Dossier

OHTUVAYRE

ENSIFENTRINE · Verona Pharma, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for OHTUVAYRE, covering 2024-06-26 to 2024-06-26. Get the full timeline:

Most recent: FDA Approved: OHTUVAYRE — Original Application (Verona Pharma, Inc.)

See pricing